期刊
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
卷 24, 期 2, 页码 188-191出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijantimicag.2004.03.014
关键词
prostatitis; Chlamydia trachomatis; azithromycin; doxycycline
The study included 125 adult patients (>18years of age) who had symptoms of chronic prostatitis and proven presence of Chlamydia trachomatis. The presence of C. trachomatis was confirmed in expressed prostatic secretion or in voided bladder urine collected immediately after prostatic massage by a DNA/RNA hybridization method and/or by isolation on McCoy culture and then by immunofluorescent typing with monoclonal antibodies. The patients were randomized in the ratio 2/1; azithromycin/doxycycline, to receive a total of 4.0 g azithromycin over 4 weeks, given as a single dose of 1x1000 mg weekly for 4 weeks or doxycycline 100 mg b.i.d. for 28 days. Patients' sexual partners were treated at the same time. Clinical and bacteriological efficacy was evaluated 4-6 weeks after the end of therapy. In the group of patients with chlamydial infection of the prostate, there was no significant difference between the eradication rates (azithromycin 65/82, doxycycline 33/43; P=0.82) and the clinical cure rates (azithromycin 56/82, doxycycline 30/43; P=0.94) of the two antimicrobials. (C) 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据